1. Home
  2. PBH vs CGNX Comparison

PBH vs CGNX Comparison

Compare PBH & CGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBH
  • CGNX
  • Stock Information
  • Founded
  • PBH 1996
  • CGNX 1981
  • Country
  • PBH United States
  • CGNX United States
  • Employees
  • PBH N/A
  • CGNX N/A
  • Industry
  • PBH Biotechnology: Pharmaceutical Preparations
  • CGNX Industrial Machinery/Components
  • Sector
  • PBH Health Care
  • CGNX Industrials
  • Exchange
  • PBH Nasdaq
  • CGNX Nasdaq
  • Market Cap
  • PBH 4.1B
  • CGNX 4.7B
  • IPO Year
  • PBH 2005
  • CGNX 1989
  • Fundamental
  • Price
  • PBH $89.13
  • CGNX $31.58
  • Analyst Decision
  • PBH Buy
  • CGNX Buy
  • Analyst Count
  • PBH 5
  • CGNX 11
  • Target Price
  • PBH $94.00
  • CGNX $41.27
  • AVG Volume (30 Days)
  • PBH 364.1K
  • CGNX 2.6M
  • Earning Date
  • PBH 05-08-2025
  • CGNX 04-30-2025
  • Dividend Yield
  • PBH N/A
  • CGNX 1.01%
  • EPS Growth
  • PBH 2.88
  • CGNX 20.86
  • EPS
  • PBH 4.29
  • CGNX 0.69
  • Revenue
  • PBH $1,137,762,000.00
  • CGNX $919,754,000.00
  • Revenue This Year
  • PBH $2.48
  • CGNX $6.38
  • Revenue Next Year
  • PBH $2.40
  • CGNX $10.30
  • P/E Ratio
  • PBH $20.31
  • CGNX $45.76
  • Revenue Growth
  • PBH 1.10
  • CGNX 8.56
  • 52 Week Low
  • PBH $62.35
  • CGNX $22.67
  • 52 Week High
  • PBH $90.04
  • CGNX $53.13
  • Technical
  • Relative Strength Index (RSI)
  • PBH 63.92
  • CGNX 68.52
  • Support Level
  • PBH $85.40
  • CGNX $31.36
  • Resistance Level
  • PBH $88.64
  • CGNX $32.15
  • Average True Range (ATR)
  • PBH 2.16
  • CGNX 0.81
  • MACD
  • PBH 0.70
  • CGNX 0.62
  • Stochastic Oscillator
  • PBH 97.76
  • CGNX 90.52

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

Share on Social Networks: